Patents by Inventor Bernhard Hassel

Bernhard Hassel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising pimobendan
    Publication number: 20050203097
    Abstract: The invention relates to novel solid formulations comprising as pharmaceutically active compound pimobendan and to processes for producing such solid formulations. The invention furthermore relates to a method for manufacturing a medicament for the prevention and/or treatment of congestive heart failure, wherein the solid formulations according to the invention are used.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 15, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Folger, Bernhard Hassel, Stefan Henke, Jens Schmalz
  • Highly concentrated stable meloxicam solutions for needleless injection
    Publication number: 20030119825
    Abstract: Aqueous cyclodextrin-free solution of meloxicam suitable for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being from 35 to 100 mg/ml. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: December 9, 2002
    Publication date: June 26, 2003
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Andreas Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Highly concentrated stable meloxicam solutions
    Publication number: 20020035107
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: May 18, 2001
    Publication date: March 21, 2002
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox